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Abstract
Background: The Government of Tajikistan is reforming its health system to make access more equitable.
Nonetheless, out-of-pocket expenditures (OPE) remain a key modality for purchasing health care. Drugs remain a
major driver of household expenditures for health. We conducted a household survey to investigate drug
prescribing patterns at primary health care (PHC) level as well as the related OPE.
Methods: Adult patients in eight districts who had visited a PHC facility in the period March to May 2014 were
interviewed at home, using a structured questionnaire. A descriptive analysis was conducted and regression models
were constructed to identify factors influencing the number of drugs provided and the types of drugs prescribed.
Results: There were 1281 (80.1 %) patients who received a drug prescription after visiting a doctor at PHC level. 16.
2 % of them had five or more drugs prescribed concomitantly. The number of drugs prescribed to patients ranged
from 0 to 8 and was statistically different across regions (RRS region =3.3; Khatlon region = 3.1; p = 0.05), after
adjusting for age and sex. In 31.1 % of cases, prescriptions included an intra-venous (IV) injection; in 45.6 % of cases,
a non-IV injection; in 52.9 % of cases, an antibiotic; and in 61.0 % of cases, vitamins. Patients suffering from a
respiratory disease had higher odds of being prescribed an IV injection and antibiotics. Vitamins were widely
prescribed across all diseases. In 94.5 % of cases, the patients interviewed procured at least one of the prescribed
drugs. Among those who received a prescription, 2.0 % were not able to procure at least one drug due to a lack of
money. In 94.9 % of cases, respondents reported purchasing drugs in private pharmacies. Median expenditures for
drugs procured following consultation were 45 TS (US$ 6.9) corresponding to 77.6 % of total expenditures related
to the visit (58 TS, US$ 8.8).
Conclusions: In a context where OPE are important, drugs represent an important income source for health service
providers. Such a situation does not favour rational prescribing nor efficient service delivery, and is potentially
harmful for patients. In particular, the economic ramifications cause high levels of expenditure for patients and
households with detrimental, knock-on effects in the more vulnerable segments of the population.
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Background
Tajikistan is a landlocked and mountainous country in
Central Asia with approximately 8.3 million inhabitants,
most of whom (73.3 %) live in rural areas [1]. It is classi-
fied as a lower middle income country with a Gross
Domestic Product (GDP) per capita of US$ 2655 (in
current international dollar, purchasing power parity) in
2014 and a GDP growth of 6.7 % in 2014 [1]. Tajikistan
faces a double burden of both high communicable and
non-communicable disease rates. Anaemia and malnu-
trition are other pressing health concerns.
After the collapse of the Soviet Union in 1991, and
Tajikistan’s independence and subsequent civil war, a
dramatic decrease of government health expenditure
occurred, which triggered the system’s dependence on
private out-of-pocket payments, including informal, under-
the-table payments [2]. However, total health expenditure
remains low and was estimated to amount to 6.8 % in
2013 [3], although this was still a higher share of GDP
devoted to health in 2013 than in any of the other –
and wealthier – Central Asian states (Kazakhstan,
Kyrgyzstan, Turkmenistan and Uzbekistan). Given its
low GDP per capita, Tajikistan had the lowest per
capita spending on health in the WHO European
Region in 2013, amounting to only USD 170 (current
international dollar, purchasing power parity) [4], and
the country’s health system remains underfunded.
Previously focusing on secondary and tertiary health
care, since 2002 the government has shown commit-
ment to foster the role of primary health care (PHC),
although the share of government funds devoted to
PHC, at 34.8 % in 2013 [5], remains comparatively
low. Being governmental employees, family doctors
working at PHC level earn low wages. They were
estimated to range between US$ 123 and US$ 153 per
month in 2013 such that workers often rely on informal
payments and in-kind contributions to earn additional
income [5].
Private out-of-pocket payments are nowadays the
main source of health financing in Tajikistan, account-
ing for 60.1 % of total health expenditure in 2013 [3].
Out-of-pocket expenditure (OPE) for health is defined
by the World Health Organization as “any direct outlay
by households, including gratuities and in-kind payments,
to health practitioners and suppliers of pharmaceuticals,
therapeutic appliances, and other goods and services
whose primary intent is to contribute to the restoration or
enhancement of the health status of individuals or popula-
tion groups” [3]. Already in 2003, Falkingham reported
that “out-of-pocket payments deter people from seeking
medical assistance and once advice has been sought, from
receiving the most appropriate treatment” [6]. According
to a survey conducted in 2011, 18.8 % of households faced
catastrophic expenditure on health (defined as out-of-
pocket spending that exceeds 40 % of a households non-
subsistence spending), with this share rising to 26.7 % in
the lowest income quintile [7].
Public funding for the purchase of medicines has de-
clined significantly since 1991, but the cost of pharma-
ceuticals, most of which are imported, has increased
substantially. In 2013, only 2.8 % of government expend-
iture on health was spent on pharmaceuticals, in both
inpatient and outpatient care [5]. This contrasts with 13 %
of total (mostly public) health expenditure being spent on
pharmaceuticals in 1991 [4]. The largest share of house-
hold OPE for health is dedicated to pharmaceuticals [2].
While in many parts of the world various studies have
described and analysed drug prescribing to patients and
the purchasing of medicines, including prescription of
essential drugs through primary care practitioners, not
much is known about this issue in the Central Asian
context. One of the few studies that have been under-
taken so far examined prescribing practices of doctors in
rural PHC clinics in Uzbekistan and found “a very high use
of injections, a low rate of generic drugs prescribed, a high
use of antibiotics, and a high rate of polypharmacy” [8].
In order to analyse the situation in Tajikistan, a
household survey was conducted in 2014 to investigate
drug prescribing and purchasing patterns among
patients who visited a PHC facility. This survey was the
follow-up of two rounds of earlier surveys that aimed
to capture the scale and determinants of patients’ OPE
when using PHC services [9, 10]. The study was conducted
within the Enhancing Primary Health Care Services
project -Tajikistan, a bilateral health service development
project funded by the Swiss Agency for Cooperation and
Development, aiming at improved population health and
enhanced access to health services.
Methods
Questionnaire, study population and sampling strategy
A cross-sectional and community-based study was carried
out among patients who had visited a PHC facility in the
period March to May 2014. A structured questionnaire
(Additional file 1) was used to ask patients about their ex-
perience with PHC services and with the prescription and
purchase of drugs during their most recent visit of a gov-
ernmental health service provider. Questions on total OPE
and demographics were also included in the questionnaire.
The study covered eight predominantly rural dis-
tricts in Tajikistan. Dangara, Hamadoni and Vose
districts are part of the Khatlon region while Faizabad,
Rudaki, Shakrinav, Tursunzade are part of the Region
of Republican Subordination (RRS). A multi-level sam-
pling strategy was used to select the study population
representing the respective geographic location. The
number of PHC facilities that were included in the study
was determined proportionally to the total number of
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PHC facilities within a given district. Their geographical
accessibility was then taken into account, with 50 % of
facilities included in the survey classified as remote and
50 % as more accessible, based on the distance to the dis-
trict capital. The second stage concerned the selection of
patients themselves. In each district, the number of pa-
tients to include was established proportionally to the
total number of adult patients a particular facility had
received in the previous year, as captured by the national
health information system. Thus, the number of respon-
dents from each facility was proportional to the total
number of patients reported to have visited that facility in
the previous year.
Facility registries of PHC providers were then used to
select patients randomly. All included health service
providers were staffed with at least one doctor, either a
family doctor (FD) or a specialist.
The sample size requirement was based on the premises
to detect at least a 10 % difference in total out-of-pocket
payments and a 7 % difference in access to medicine
across three socioeconomic groups using a power of 90 %
and a significance level of 5 %. It resulted in a required
sample of 750 patients. It was then decided to round up to
800 patients and we further doubled the sample size to
1600 patients so as to be able to stratify along the four
districts which had been covered in the previous surveys
and along those four newly included ones.
Data collection and analysis
Patients were visited at home and interviewed by trained
interviewers. Information on drug prescription and pro-
curement following their last visit to a PHC facility was
based on their memory and, if available, the prescription.
Data were collected and entered using tablets in June
2014 by Zerkalo, Centre for Sociological Research. In
addition, there was an independent monitor in charge of
quality assurance in order to ensure that the outlined
methodology was respected.
Data were analysed using Stata 13 software. Qualita-
tive variables were described by absolute value, percent-
age and 95 % confidence interval based on binomial
law. Quantitative variables were described by their
absolute value, the mean, and a 95 % confidence inter-
val of the mean, a standard deviation, median and
range. Regression models were constructed to identify
factors influencing the number of drugs provided to
patients and the types of drugs prescribed. Results were




In the eight study districts, 1611 patients were randomly
selected to be followed up at home and interviewed.
However, 446 (27.7 %) of them could not be interviewed
at home after three attempts and were replaced by
another eligible patient who had previously visited a
PHC facility. Finally, 1599 adult patients were included
in the analysis; 18.6 % of respondents were male and
81.4 % were female (Table 1). The median age of respon-
dents was 30 years, the median number of years of
education was 10 and the median number of visits to a
PHC service provider in the past 12 months was 4.
In 26.1 % of cases, visits to PHC services were due to
respiratory diseases, 17.1 % were related to pregnancy,
12.1 % to cardiovascular diseases, 9.8 % to gastrointestinal
diseases, 8.8 % to diarrhoea, 8.2 % to genitourinary diseases,
5.2 % to anaemia and 1.2 % to diabetes.
Drug prescription
The vast majority of respondents (1281 patients, equiva-
lent to 80.1 % of the sample) reported having received a
drug prescription during their visit to a PHC provider
(Table 2). The median number of drugs prescribed by
the FD was 3, ranging from 1 to 8 or more, the first and
third quartiles attaining 2 and 4 respectively (Table 2).
The median number of drugs procured by patients was 3,
with a range and quartiles equivalent to the number of
drugs prescribed. 259 (16.2 %) patients were prescribed
five or more drugs concomitantly, meeting the generally
accepted threshold for polypharmacy [11] (Table 2).
Although the difference was not statistically significant,
women more often received antibiotics (53.8 % vs 49.0 %)
and vitamins (62.5 % vs 54.4 %) after consulting their FD.
The older the patient, the higher the number of drugs pre-
scribed (3.0 among those 18 and 35 years old; 3.5 among
those 36 and 55 years old; 3.9 among those older than 55;
p < 10-3). Along this, the likelihood for an antibiotic injec-
tion increased. Regional disparities were observed, with
patients living in Khatlon region receiving fewer drugs,
after adjustments for age and gender (3.3 in the RRS vs
3.1 in the Khatlon region p < 0.05) (Table 3).
Characteristics of the drugs prescribed
When a prescription was issued (N = 1281), it included
an intravenous injection in 31.1 % of cases; a non-
intravenous (intradermal or intramuscular) injection in
45.6 % of cases and an antibiotic in 52.9 % of cases.
Vitamins were issued in 61.0 % of cases (Table 4). The
number of drugs prescribed was lowest when consult-
ing for diabetes (mean of 2.7 and SD = 1.8) and highest
when consulting for injuries (mean of 3.9 and SD = 2.0)
(Table 4). Diabetics were the most likely to receive a pre-
scription of an intravenous injection (60.0 %) while
patients consulting for a genitourinary disease (supposedly
infections) were most likely to be prescribed an antibiotics
(64.4 %). Suffering from a respiratory disease increased
the odds of being prescribed an antibiotic, after age and
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gender were adjusted for. Finally, vitamins and non-
intravenous drugs were widely prescribed across all
diseases (Table 5).
Drug procurement
Of the total number of patients who had received a pre-
scription, 94.5 % were able to obtain at least part of the
drugs while the remaining 5.5 % were unable to obtain
their full prescription. Those who were not able to get
drugs (N = 71) indicated that a lack of money was the
most important reason (35.2 % of cases). Some patients
did not feel the need to buy one or more of the pre-
scribed drugs (23.9 % of cases). In 9.9 % of cases,
patients declared not obtaining drugs due to a pharmacy
being difficult to access geographically. It is noteworthy
that at the pharmacy level, difficulties within the distri-
bution chain also became apparent, as 7.0 % of patients
reported stock-outs of a given drug in the 3 months
assessment period (Table 6).
Private pharmacies are the most common place for drug
procurement: 94.9 % of patients who procured at least one
drug did so from a private vendor. In some few instances,
the drugs were procured at a hospital (1.2 % of inter-
viewees with at least one drug prescribed). The remaining
patients reported obtaining drugs from the market (1.2 %)
or free of charge from a PHC provider (1.5 %).
Expenditures for drugs
The visit to a governmental PHC provider was related to
total median expenditures of 58 TS (US$ 8.8) (mean
expenditures of 121 TS; US$ 18.5; SD = 259) which
included expenditures for admission, transportation and
drugs. These costs were substantial and corresponded to
a relevant share of household expenditures.
The median amount of money spent on drugs amounted
to 45 TS (US$ 6.9) (mean expenditures of 98 TS; US$
15.0; SD = 223), corresponding to 77.6 %, respectively
more than three-quarters of the total household expend-
iture made in the course of a visit to a PHC provider.
Discussion
Limitations
More than 22 % of the patients initially selected through
our sampling strategy were not interviewed, as most of
them could not be found at home. Hypothetically, these
458 patients could have had systematically different
answers from the ones who were interviewed, introdu-
cing selection bias. Although our findings on prescribing
patterns are in line with previous research conducted in
Table 2 Drug prescription during consultation
Variable Number Percent
Drug prescription 1281 80.1
Median number of drugs prescribed 3
Prescription with > = 5 drugs 259 16.2
Table 1 Patients’ characteristics
Variable Number Percent
Number of respondents 1599 100
Gender Female 1302 81.4
Male 297 18.6
Median Age 30
Median number of years of education 10
Region RRS 575 36.0
Khatlon 1024 64.0
Median number of visits to a FD in the past 12 months 4
Reasons to consult Respiratory diseases 418 26.1
Cardiovascular diseases 193 12.1
Pregnancy 274 17.1
Gastrointestinal diseases 156 9.8
Diarrhoea 140 8.8




Skin disease 22 1.4
Other 119 7.4
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Central Asia, the precise figures need therefore to be
interpreted with caution. Additionally, our sample over-
represented females compared to males. Three reasons
were identified to explain this situation: (1) in rural areas
of Tajikistan, many males are working as labour mi-
grants in Russia so that the demographic weight of
women in the study regions is substantially higher; (2)
PHC services are typically used by women and children
so that their representation in the sample is expected to
be higher and (3) as men were more frequently working
and not at home at the time of the interview, they were
in some instances replaced by a female patient. Further-
more and as the main focus of the study was to have
representative information on patients’ OPE and on drug
prescribing, the study was not assessing whether patients
consulted for the first time or in the frame of a follow-
up visit. However, the nature of the visit (first visit or
follow-up) may influence the size of expenditures which
is related to drug prescribing patterns.
Since our aims were to investigate both drug prescribing
patterns and consequent OPE, we deemed interviewing
patients to be the most informative and insightful method
of investigation. However, while the household perspective
enabled us to collect information on both purchasing and
prescribing patterns, recall bias cannot be ruled out, in
particular with regard to drug prescribing. We aimed to
minimize this risk by using a short timeframe between FD
consultations and interviews and, wherever possible, by
making use of available prescriptions.
Drug prescription
In Tajikistan, doctors at PHC level seem to overprescribe
drugs, in view of the number of drugs prescribed con-
comitantly and the high level of polypharmacy [11]. It
can be explained by the low official salary FD earn from
the government, estimated to range between US$ 123
and US$ 153 per month in 2013 [5] which is not enough
to cover essential needs. As a consequence, doctors often
rely on informal payments and in-kind contributions from
patients. Expenditures for drugs represented 2.8 % of
governmental health budget in 2013 [2] so that pharma-
ceuticals are mainly financed by patients through informal
OPE (both at hospital and primary care level). Such condi-
tions do not favour rational prescribing as the prescription
of a high number of drugs can represent a complementary
income source to doctors and pharmacists.
In most cases, patients reported trusting their doctor’s
advice and there was little self-procurement of drugs
without prescriptions. However, the results also highlight
geographical disparities between districts of republican
subordination (RRS) and Khatlon region (p = 0.05).
Reasons could be that doctors and pharmacists are more
Table 3 Drug prescribing by gender, age and region (N = 1281)
Variable Gender Age Region
Female Male 18-35 36-55 >55 RRS Khatlon
N (%) 1042 (81.3) 239 (18.7) 828 (64.6) 330 (25.8) 123 (9.6) 439 (34.3) 842 (65.7)
Mean number of drugs* 3.2 3.3 3.0 3.5 3.9 3.3 3.1
SD 1.5 1.4 1.4 1.5 1.7 1.5 1.4
% IV injections 31.4 29.7 23.4 37.9 64.2 37.2 19.4
% non IV injections 45.9 44.4 40.2 55.2 56.1 50.2 36.7
% Antibiotics 53.8 49.0 48.7 61.8 57.7 56.7 45.8
% Vitamins 62.5 54.4 62.0 59.1 59.4 62.2 58.5
* The differences are significant across age groups (P < 10-3) and across regions (P < 0.05) after age and gender adjustments
Table 4 Drug prescribing by reason to consult (N = 1281)
Variable Reason to consult
All Respiratory Digestive Cardiovascular Diarrhoea Pregnancy Genitourinary Injuries Skin disease Diabetes Anaemia Other
N 1281 324 115 156 114 220 101 38 22 15 74 102
Mean number
of drugs
3.2 3.1 3.2 3.6 3.1 2.9 3.8 3.9 3.1 2.7 3.1 3.5
SD 1.5 1.3 1.5 1.7 1.2 1.3 1.6 2.0 1.2 1.8 1.4 1.6
% IV
injections
31.1 17.9 28.7 50.0 29.0 26.8 47.5 42.1 4.6 60.0 40.5 32.4
% non IV
injections
45.6 44.1 44.4 48.1 36.8 42.7 65.4 57.9 22.7 46.7 50.0 41.2
% Antibiotics 52.9 66.7 50.4 49.4 47.4 40.9 64.4 60.5 31.8 53.3 51.4 41.2
% Vitamins 61.0 63.6 64.4 55.8 60.5 66.8 57.4 44.7 54.6 40.0 68.9 52.9
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widely influenced by the pharmaceutical industry in the
RRS, being geographically close to the capital city
Dushanbe. Another hypothesis could be that the RRS
region hosts a higher proportion of well-off households
than the Khatlon region with patients having a higher
purchasing power, utilizing health services more fre-
quently. In support of the latter hypothesis is earlier
research that found that richer groups of the population
utilize health services more than poorer groups. In the
2011 Panorama Household Survey, utilization of out-
patient care by the richest quintile was almost twice as
high as by the poorest quintile and utilization of inpatient
care was almost three times higher among the richest
quintile compared with the poorest quintile [7].
Characteristics of the drugs prescribed
Vitamins were issued in 61.0 % of cases, an extremely
high number that cannot be explained by the prevalence
of diseases caused by micronutrient deficiencies. The
characteristics of the drugs prescribed were similar to
those found in Uzbekistan [8]. Vitamin injections or
intravenous rehydration were also found to be com-
monly prescribed in a study on TB patients in Tajikistan
[12]. In addition to being of questionable clinical value
and inducing an unnecessary financial burden on vulner-
able households when oral drugs could be a cheaper
alternative, injections are associated with the risk of
infections and thus potentially harmful to patients. This
is in line with research in other former Soviet countries,
including Tajikistan, which found that clinical practice is
still far from internationally accepted evidence and that
many harmful practices persist [13].
Our findings on the excessive use of antibiotics are in
line with previous studies that have shown the inappropri-
ate use of antibiotics in Tajikistan [14]. The high prescrip-
tion of antibiotics results in increased drug expense,
exacerbates drug resistance, and presents a danger to the
health of the population which could ultimately under-
mine trust in the health sector. A recent study of low- and
middle-income countries found that patient co-payments
in the public sector were associated with an increased use
of antibiotics, potentially due to supply-side incentives and
underdeveloped mechanisms for quality assurance [15].
This corroborates well established evidence on the effects
of fee-for-services arrangements, which tend to lead to
excessive investigations, treatment and prescription [16].
Table 5 Multivariate analysis showing variables influencing the odds of buying different types of drugs (N = 1281)










Age -0.009 (-0.01- -0.007) 0.000 -0.006 (-0.008- -0.004) 0.000 -0.004 (-0.007- -0.001) 0.002 0.874
Gender -0.12 (-0.19- -0.05) 0.000 0.066 0.052 0.103
Reason to
consult
Respiratory 1 1 1 1
Digestive -0.11(-0.21- -0.008) 0.034 0.799 0.22 (0.09-0.34) 0.001 0.998
Cardiovascular -0.21(-0.30- -0.11) 0.000 0.378 0.23 (0.11-0.35) 0.000 0.177
Diarrhoea -0.12(-0.22- -0.025) 0.014 0.235 0.22 (0.09-0.34) 0.001 0.411
Pregnancy -0.13(-0.21- -0.046) 0.002 0.914 0.25 (0.14-0.35) 0.000 0.89
Genitourinary -0.26(-0.36- -0.16) 0.000 -0.18 (-0.29- -0.064) 0.002 0.21 0.113
Injuries -0.16(-0.31- 0.00) 0.050 0.339 0.517 0.21 (0.026-0.40) 0.026
Skin disease 0.097 0.23 (0.005-0.45) 0.045 0.38 (0.12-0.63) 0.004 0.376
Diabetes -0.25(-0.26- -0.03) 0.048 0.478 0.266 0.164
Anaemia -0.15(-0.26- -0.03) 0.013 0.849 0.19 (0.04-0.34) 0.011 0.958
Other 0.085 0.241 0.32 (0.19-0.46) 0.000 0.13 (0.009-0.26) 0.036
Table 6 Drug procurement
Variable Number Percent
Drugs obtained after being prescribed (N = 1281) 1210 94.5
Reasons for not obtaining (N = 71) No pharmacy near by 7 9.9
Lack of money 25 35.2
Medicine not in stock 5 7.0
No felt need 17 23.9
Other 17 23.9
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An added challenge in countries such as the former Soviet
ones is the existence of informal, under-the-counter
payments which not only lead to perversive incentives for
physicians, but also errode transparency and accountability
more generally [17].
Drug procurement
Private drug-selling retail points have grown across
the country over the past decade which substantially
improved drug availability in Tajikistan. However, the
predominant role of the private sector and the under-
developed regulatory environment have led to an
underuse of generic drugs over the delivery of brand
names. Already in 2005, the inclusion of 139 brand
names in the Tajikistan Essential Drug List was a source of
concern for the WHO, suggesting that the Tajik govern-
ment had not embraced the promotion of generic drugs,
and instead allowed the entry of expensive drugs into the
market which the country could not afford [18]. Although
the situation has improved since then, the lack of
evidence-based guidelines, the insufficient education of
doctors and pharmacists, and the pressure from the
pharmaceutical industry all result in irrational prescribing
practices. The prescription of brand names instead of
International Nonproprietary Names (INN) for pharma-
ceutical substances means that patients purchase expen-
sive drugs instead of generics, ultimately impairing access
of poor households to health care.
Expenditures for drugs
Despite ongoing health reforms aiming to improve cover-
age and financial protection, OPE remain substantial. In
our study, expenditures on drugs represented the biggest
financial burden for patients accessing a primary care
facility. One of the few studies published on the burden of
this expenditure to household income in Tajikistan indi-
cates, using 2003 data, that around 5 % of the household
income is allocated to health [19]. Additional evidence
from 2011 indicates that as a consequence of the substan-
tial reliance on OPE, 26.7 % of households in the lowest
consumption quintile are at risk of catastrophic health
expenditure by spending over 40 % of their non-
subsistence spending on health [20].
With the continuing predominance of OPE to finance
health services and without a social risk protection
scheme, Tajik households are put at risk of impoverish-
ment and of catastrophic health expenditure in case of
major illness episodes. These results suggest that the
health reforms being implemented in Tajikistan aiming
to offer free primary care services, reduce OPE and
strengthen the role of family medicine, including
through the Basic Benefit Package, do not yet yield the
expected benefits.
Conclusion
In conclusion, analysis of the survey we conducted in
2014 in rural and semi-urban Tajikistan showed a high
rate of drug prescription, an irrational use of antibiotics
and vitamins and the common use of injections to admin-
ister medicines at the PHC level. Expenditures for drugs
represented more than three-quarters of the total amount
paid in the course of a visit to a PHC provider. It resulted
that a third of the interviewees who did not obtain the
drugs prescribed explained it to their inability to pay.
Efforts to develop, disseminate and ensure implemen-
tation of national protocols and guidelines for PHC pro-
viders need to be strengthened to improve rational and
evidence-based prescribing. This includes doctors using
INN when issuing a prescription to allow the dissemin-
ation of generic drugs. The resulting private and public
resource savings could be allocated to other parts of the
health system.
On the demand side, it is crucial to raise the popula-
tion’s awareness of generic drugs so as not to impair
their trust in the behaviour of physicians and pharma-
cists. Communication should also be encouraged to
explain the rational use of antibiotics, safer and cheaper
ways of administrating medications and the limited clin-
ical value of vitamin supplements (except for vitamin
deficiencies).
In the Tajik context where OPE are important, drugs
represent an important income source for various health
system players, principally pharmacists incentivized to
deliver drugs without prescription to increase their
salary. Such situations do not favour rational prescribing
nor efficient service delivery, and are potentially in-
appropriate or even harmful for patients. Patients’ and
households’ interests are put at risk, especially the more
vulnerable segments of the population.
Additional file
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